Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2003
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003WO2003097648A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the prepartion thereof
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003US20030220509 Conversion of the hydroxysulfone group into the acetamidosulfone group; enzyme inhibitors of the carbonic anhydrase, for the treatment of elevated intraocular pressure
11/27/2003US20030220365 Administering a biheterocyclic compound for treating reperfusion injuries and inflammatory diseases
11/27/2003US20030220319 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders
11/27/2003US20030220318 New phenylalanine derivatives
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003CA2485214A1 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/26/2003EP1363918A1 Copolymer composition having pigment like properties
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1119559B1 3-phenyl-pyrones
11/26/2003EP0756599B1 Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists
11/26/2003EP0605474B1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
11/26/2003CN1458933A Thienopyrimidine compounds and their salts and process for preparation of both
11/26/2003CN1128805C Polymorphic clopidogrel hydrogenesulphate form and its preparing method and pharmaceutical compositions
11/26/2003CN1128802C Phenyl-substituted cyclic ketoenol and pesticide and herbicide
11/25/2003US6653476 Thienopyridine derivatives, their production and use
11/25/2003US6653314 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
11/25/2003US6653306 Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653290 Tumor proliferation inhibitors
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003057173A3 Broad spectrum inhibitors
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216585 Reacting 2,5-diester-3.4-dihydroxythiophene with epichlorhydrin
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216540 Alkylenedioxythiophenes and poly(alkylenedioxythiophene)s having urethane-containing side groups
11/20/2003US20030216429 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216385 Triazole derivatives
11/19/2003EP1362859A1 Process for preparing a 2-hydroxymethyl-2, 3- dihydro-thieno(3, 4-b) (1, 4) dioxine-5, 7-dicarboxylic acid diester
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361875A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1216250B1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
11/19/2003EP1017735B1 Compounds for electronic devices
11/19/2003EP0898571B1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457260A Reusable extracorporeal colums loaded with ligand-dibiotin conjugates
11/19/2003CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines
11/19/2003CN1456154A Method for curing sepsis
11/18/2003US6649619 Compounds
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/13/2003WO2003093276A1 A process for the preparation of clopidogrel
11/13/2003WO2003093261A1 Phthalazinone derivatives
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003053331A3 Protease inhibitors
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors
11/13/2003US20030212271 Reacting dialkyl malonate ester with trifluoroacetic acid; cyclization, controlling temperature
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212081 Bicyclic heteroaromatic compounds useful as LH agonists
11/13/2003US20030212079 Antiischemic agents; central nervous system disorders
11/13/2003US20030212061 Aza-thioxanthenones with antitumor activity
11/13/2003US20030209692 Reactive mesogenic benzodithiophenes
11/13/2003CA2485070A1 A process for the preparation of clopidogrel
11/13/2003CA2482806A1 Phthalazinone derivatives
11/12/2003EP1359943A2 Biotin-derivates and their conjugates with chelating agents
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/12/2003CN1127498C Pyridine derivatives, process for preparing the same, and intermediate therefor
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645989 Compounds
11/06/2003WO2003091260A1 Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091255A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002083083A3 Pharmaceutically active compounds and methods of use
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030208077 Hydroxyacetic ester derivatives, preparation method and use as synthesis intermediates
11/06/2003US20030208066 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
11/06/2003US20030207922 Diketoacids useful as inhibitors of viral polymerases, in particular hepatitis C virus, RNA dependent RNA polymerase, hepatitis B virus polymerase and reverse transcriptase of human immunodeficiency virus
11/06/2003US20030207900 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma
11/06/2003US20030207880 Heterocycle carboxamides as antiviral agents
11/06/2003US20030207878 Drugs used as angiogenesis inhibitors, vascular permeability or endothelial growth factor antagonists, for prophylaxis of cancer, diabetes, psoriasis, arthritis, autoimmune diseases, inflammation or scar formation
11/06/2003US20030205701 Highly stable and efficient nonlinear optical chromophores for electro-optic polymers
11/06/2003CA2483496A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003CA2481324A1 [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
11/05/2003EP1359152A2 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1357915A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/05/2003EP1135136B1 Pharmaceutical compositions containing olanzapine-n-oxide
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/04/2003US6642268 Treatment of hyperlipidemic conditions such as those associated with atherosclerosis or hypercholesterolemia, in mammals.
11/04/2003US6642260 Nitric oxide donors and pharmaceutical compositions containing them
11/04/2003US6642249 3-Oxo-pyrazolo(4,3-c) -quinolin-2-yl, -thiochroman-2-yl, or -chromen-2-yl derivatives; CD80 antagonists
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 214